Skip to content

News & Insights

Perspectives and analyses from the Fool Ventures team and what's happening across our portfolio.

Micro1 raises over $100M at a $4 billion valuation, backed by xAI cofounders
September 22, 2026

Micro1 raises over $100M at a $4 billion valuation, backed by xAI cofounders

Micro1 supplies frontier AI labs, Microsoft, Amazon, and robotics companies with the human-made data they need to train and evaluate models — and in a little over a year, the company has gone from a $7M business to a ...

Read more
micro1 selected to support the Department of Energy's Genesis Mission
September 1, 2026

micro1 selected to support the Department of Energy's Genesis Mission

The Department of Energy is calling it the Manhattan Project of AI. micro1 has been picked to help power the inaugural Genesis Mission, bringing its work in technical data, evaluation, and expert review to the national ...

Read more
micro1 turned an AI recruiter into a $2.5B data lab
August 11, 2026

micro1 turned an AI recruiter into a $2.5B data lab

Micro1 built an AI recruiter that screens experts to train frontier AI models, and it's now growing at 6,963% with revenue jumping from $7 million to over $400 million in a year. Founder Ali Ansari is 25, on leave from ...

Read more
Function secures $450M to scale preventive care
July 31, 2026

Function secures $450M to scale preventive care

Function just closed a massive $450M non-dilutive round from General Catalyst to double down on early detection. Offering 160+ labs plus cancer and stroke screenings for $365/year, the startup is betting that keeping ...

Read more
Christina Qi talks Databento on Fortt Knox
July 29, 2026

Christina Qi talks Databento on Fortt Knox

In this Fortt Knox conversation, Databento CEO Christina Qi tells Jon Fortt why she walked away from Domeyard and rebuilt market data infrastructure from scratch: her own servers colocated inside the exchanges, sold ...

Read more
Madison Reed's founder joins Pendulum's board
July 13, 2026

Madison Reed's founder joins Pendulum's board

Pendulum Therapeutics turns microbiome science into real treatments, including the first probiotic clinically proven to lower A1C in people with Type 2 diabetes. The company just added Amy Errett, the four-time ...

Read more

Browse additional perspectives from the team and portfolio news coverage. Recent items appear by default, with older coverage available by year.

No results matched your search yet. Try a broader keyword or clear the search to browse by year.
From the team
Video Archive
Article Archive